Home › Asset managers › Compare 2025-2026 › BlackRock vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,192 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
BlackRock 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 37,817 | 27,805 | 2,443 | 7,569 | 91.9% | 85.0% |
| Board proposals | 30,219 | 21,602 | 2,017 | 6,600 | 91.5% | 84.4% |
| E&S shareholder proposals | 163 | 0 | 1 | 162 | 0.0% | 38.7% |
| Other items | 7,435 | 6,203 | 425 | 807 | 93.6% | 88.2% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
6,600 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | BlackRock | Brighthouse |
|---|---|---|---|---|---|---|
| 10X GENOMICS, INC. | June 4, 2026 | A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; Say-on-Pay |
Board | For | FOR 27 funds |
Split 4 FOR, 1 ABSTAIN |
| 10X GENOMICS, INC. | June 4, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; Audit-related |
Board | For | FOR 13 funds |
Split 4 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval of an amendment to our Certificate of Incorporation, as amended, to increase the total number of authorized shares of our common stock, par value $0.001 per share, from 220,000,000 shares to 440,000,000 shares. Capital Structure |
Board | For | FOR 8 funds |
Split 1 FOR, 1 AGAINST |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval of the amendment and restatement of the 2015 Incentive Plan to increase the number of shares reserved for issuance thereunder by 4,000,000 shares and to extend the term until 2036. Compensation |
Board | For | FOR 8 funds |
Split 1 AGAINST, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval, on an advisory basis, of the compensation paid to our named executive officers in 2025. Say-on-Pay |
Board | For | FOR 15 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Charles G. McClure, Jr. Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Jeffrey A. Graves Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Jim D. Kever Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: John J. Tracy Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Kevin S. Moore Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Malissia R. Clinton Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Thomas W. Erickson Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The election of the nine directors named in the accompanying Proxy Statement: Vasant Padmanabhan Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| 3M COMPANY | May 12, 2026 | Advisory approval of executive compensation. Say-on-Pay |
Board | For | FOR 75 funds |
Split 4 FOR, 1 AGAINST, 6 ABSTAIN |
| 3M COMPANY | May 12, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as 3M's independent registered public accounting firm. Audit-related |
Board | For | FOR 53 funds |
Split 4 FOR, 1 AGAINST, 6 ABSTAIN |
| 8X8, INC. | July 25, 2025 | To approve, through an advisory vote, 8x8, Inc.'s executive compensation for the fiscal year ended March 31, 2025. Say-on-Pay |
Board | For | FOR 19 funds |
Split 2 FOR, 1 ABSTAIN |
| 8X8, INC. | July 25, 2025 | To ratify the appointment of Grant Thornton LLP as 8x8, Inc.'s independent registered public accounting firm for the fiscal year ending March 31, 2026. Audit-related |
Board | For | FOR 11 funds |
Split 2 FOR, 1 ABSTAIN |
| 908 DEVICES INC | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 10 FOR, 1 AGAINST |
AGAINST 1 fund |
| A. O. Smith Corporation | April 13, 2026 | Proposal to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the corporation: Audit-related |
Board | For | FOR 33 funds |
Split 3 FOR, 2 ABSTAIN |
| A10 NETWORKS, INC. | April 22, 2026 | To approve, on an advisory and non-binding basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 35 funds |
Split 3 AGAINST, 1 ABSTAIN |
| A10 NETWORKS, INC. | April 22, 2026 | To ratify the appointment of Grant Thornton LLP as our independent public accounting firm for our fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 24 funds |
Split 3 FOR, 1 ABSTAIN |
| AAC TECHNOLOGIES HOLDINGS INC | May 21, 2026 | Approve Deloitte Touche Tohmatsu as Auditors and Authorize Board to Fix Their Remuneration Audit-related |
Board | For | Split 13 FOR, 1 AGAINST |
AGAINST 1 fund |
| AAON, INC. | May 12, 2026 | Election of Directors for a term ending in 2029: Caron A. Lawhorn Director Elections |
Board | For | FOR 23 funds |
Split 4 FOR, 2 ABSTAIN |
| AAON, INC. | May 12, 2026 | Election of Directors for a term ending in 2029: David R. Stewart Director Elections |
Board | For | FOR 23 funds |
Split 4 FOR, 2 ABSTAIN |
| AAON, INC. | May 12, 2026 | Election of Directors for a term ending in 2029: Stephen O. LeClair Director Elections |
Board | For | FOR 23 funds |
Split 4 FOR, 2 ABSTAIN |
| AAON, INC. | May 12, 2026 | Proposal to approve, on an advisory basis, a resolution on the compensation of AAON's named executive officers as set forth in the Proxy Statement. Say-on-Pay |
Board | For | FOR 36 funds |
Split 4 FOR, 2 ABSTAIN |
| AAON, INC. | May 12, 2026 | Proposal to ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 23 funds |
Split 4 FOR, 2 ABSTAIN |
| AAR CORP. | September 16, 2025 | Advisory proposal to approve our Fiscal Year 2025 executive compensation Say-on-Pay |
Board | For | Split 28 FOR, 1 AGAINST |
Split 4 FOR, 1 ABSTAIN |
| AAR CORP. | September 16, 2025 | Ratify the appointment of KPMG LLP as our independent registered public accounting firm for Fiscal Year 2026 Audit-related |
Board | For | FOR 17 funds |
Split 4 FOR, 1 ABSTAIN |
| AB SAGAX | May 8, 2026 | APPROVE WARRANT BASED INCENTIVE PROGRAM 2026/2029 FOR KEY EMPLOYEES Compensation |
Board | For | Split 1 FOR, 19 AGAINST |
FOR 2 funds |
| AB SAGAX | May 8, 2026 | RATIFY DELOITTE AS AUDITORS Audit-related |
Board | For | Split 1 FOR, 19 AGAINST |
AGAINST 2 funds |
| AB SAGAX | May 8, 2026 | REELECT JOHAN CEDERLUND AS DIRECTOR Director Elections |
Board | For | Split 19 FOR, 1 AGAINST |
AGAINST 2 funds |
| AB SAGAX | May 8, 2026 | REELECT STAFFAN SALEN AS BOARD CHAIR Corporate Governance |
Board | For | Split 19 FOR, 1 AGAINST |
AGAINST 2 funds |
| AB SAGAX | May 8, 2026 | REELECT STAFFAN SALEN AS DIRECTOR Director Elections |
Board | For | Split 19 FOR, 1 AGAINST |
AGAINST 2 funds |
| AB SAGAX | May 8, 2026 | REELECT ULRIKA WERDELIN AS DIRECTOR Director Elections |
Board | For | Split 19 FOR, 1 AGAINST |
AGAINST 2 funds |
| ABBOTT LABORATORIES | April 24, 2026 | Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees Compensation |
Board | For | FOR 61 funds |
Split 9 FOR, 3 AGAINST |
| ABBOTT LABORATORIES | April 24, 2026 | Ratification of Ernst & Young LLP As Auditors Audit-related |
Board | For | FOR 61 funds |
Split 9 FOR, 3 ABSTAIN |
| ABBOTT LABORATORIES | April 24, 2026 | Say on Pay - An Advisory Vote on the Approval of Executive Compensation Say-on-Pay |
Board | For | FOR 83 funds |
Split 9 FOR, 3 ABSTAIN |
| ABBVIE INC. | May 8, 2026 | Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026 Audit-related |
Board | For | FOR 67 funds |
Split 10 FOR, 4 ABSTAIN |
| ABBVIE INC. | May 8, 2026 | Say on Pay - An advisory vote on the approval of executive compensation Say-on-Pay |
Board | For | FOR 89 funds |
Split 9 FOR, 1 AGAINST, 4 ABSTAIN |
| ABEONA THERAPEUTICS INC. | June 12, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 9 FOR, 1 AGAINST |
AGAINST 1 fund |
| ABERCROMBIE & FITCH CO. | June 3, 2026 | Advisory vote to approve the compensation of the Company's named executive officers for the fiscal year ended January 31, 2026. Say-on-Pay |
Board | For | FOR 40 funds |
Split 4 FOR, 2 ABSTAIN |
| ABERCROMBIE & FITCH CO. | June 3, 2026 | Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 30, 2027. Audit-related |
Board | For | FOR 24 funds |
Split 4 FOR, 2 ABSTAIN |
| ABM INDUSTRIES INCORPORATED | March 25, 2026 | Advisory approval of our executive compensation. Say-on-Pay |
Board | For | FOR 30 funds |
Split 3 FOR, 1 ABSTAIN |
| ABM INDUSTRIES INCORPORATED | March 25, 2026 | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2026. Audit-related |
Board | For | FOR 15 funds |
Split 3 FOR, 1 ABSTAIN |
| ABU DHABI COMMERCIAL BANK PJSC | March 3, 2026 | Appoint or Reappoint Auditors and Fix Their Remuneration for FY 2026 Audit-related |
Board | For | Split 10 FOR, 2 ABSTAIN |
FOR 1 fund |
| ACADEMY SPORTS AND OUTDOORS, INC. | June 4, 2026 | Approval, on a non-binding advisory basis, of the fiscal 2025 compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 29 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADEMY SPORTS AND OUTDOORS, INC. | June 4, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal 2026. Audit-related |
Board | For | FOR 17 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. Say-on-Pay |
Board | For | FOR 35 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. Compensation |
Board | For | FOR 22 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 22 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. Compensation |
Board | For | FOR 23 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 37 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James M. Daly Director Elections |
Board | For | FOR 4 funds |
Split 3 FOR, 2 WITHHOLD |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 23 funds |
Split 4 FOR, 1 ABSTAIN |
| ACADIA REALTY TRUST | May 13, 2026 | THE APPROVAL, ON A NON-BINDING ADVISORY BASIS, OF THE COMPENSATION OF NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE COMPANY'S 2026 PROXY STATEMENT. Say-on-Pay |
Board | For | FOR 33 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADIA REALTY TRUST | May 13, 2026 | THE RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026. Audit-related |
Board | For | FOR 21 funds |
Split 2 FOR, 1 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 26 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Andrew Kim Director Elections |
Board | For | Split 14 FOR, 3 AGAINST |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Barbara Trebbi Director Elections |
Board | For | FOR 17 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: John Paulson Director Elections |
Board | For | Split 14 FOR, 3 AGAINST |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Kelly Young Director Elections |
Board | For | FOR 17 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Robert Chersi Director Elections |
Board | For | FOR 17 funds |
Split 2 FOR, 2 ABSTAIN |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Ratification of the appointment of KPMG LLP as the registered public accounting firm of Acadian Asset Management Inc. Audit-related |
Board | For | FOR 17 funds |
Split 2 FOR, 2 ABSTAIN |
| ACCEL ENTERTAINMENT, INC. | May 7, 2026 | Elect six (6) directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualify. Karl Peterson Director Elections |
Board | For | FOR 12 funds |
Split 1 FOR, 1 WITHHOLD |
| ACCEL ENTERTAINMENT, INC. | May 7, 2026 | Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 12 funds |
Split 1 FOR, 1 ABSTAIN |
| ACCELERANT HOLDINGS | May 12, 2026 | to consider and vote upon the ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 1 FOR, 2 ABSTAIN |
| ACCELLERON INDUSTRIES AG | April 28, 2026 | Appoint Stefano Pampalone as Member of the Nomination and Compensation Committee Corporate Governance |
Board | For | Split 1 FOR, 8 AGAINST |
FOR 1 fund |
| ACCELLERON INDUSTRIES AG | April 28, 2026 | Reelect Stefano Pampalone as Director Director Elections |
Board | For | Split 1 FOR, 8 AGAINST |
FOR 1 fund |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Alan Jope Director Elections |
Board | For | FOR 67 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Arun Sarin Director Elections |
Board | For | FOR 67 funds |
Split 7 FOR, 1 AGAINST, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Jennifer Nason Director Elections |
Board | For | FOR 67 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Julie Sweet Director Elections |
Board | For | FOR 67 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Masahiko Uotani Director Elections |
Board | For | FOR 67 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Nancy McKinstry Director Elections |
Board | For | FOR 67 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Paula A. Price Director Elections |
Board | For | FOR 67 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Tracey T. Travis Director Elections |
Board | For | FOR 67 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | To approve the Amended and Restated Accenture plc 2010 Share Incentive Plan. Compensation |
Board | For | FOR 67 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | To approve, in a non-binding vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 90 funds |
Split 7 FOR, 1 AGAINST, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | To determine the price range at which Accenture can re-allot shares that it acquires as treasury shares under Irish law. Capital Structure |
Board | For | FOR 67 funds |
Split 8 FOR, 3 ABSTAIN |
| ACCENTURE PLC | January 28, 2026 | To grant the Board of Directors the authority to issue shares under Irish law. Capital Structure |
Board | For | FOR 67 funds |
Split 8 FOR, 3 AGAINST |
| ACCENTURE PLC | January 28, 2026 | To grant the Board of Directors the authority to opt-out of pre-emption rights under Irish law. Capital Structure |
Board | For | FOR 67 funds |
Split 8 FOR, 3 AGAINST |
| ACCIONA SA | June 24, 2026 | Reelect Jeronimo Marcos Gerard Rivero as Director Director Elections |
Board | For | FOR 20 funds |
Split 2 FOR, 1 AGAINST |
| ACCIONA SA | June 24, 2026 | Reelect Maria Salgado Madrinan as Director Director Elections |
Board | For | FOR 20 funds |
Split 2 FOR, 1 AGAINST |
| ACCIONA SA | June 24, 2026 | Reelect Teresa Sanjurjo Gonzalez as Director Director Elections |
Board | For | FOR 20 funds |
Split 2 FOR, 1 AGAINST |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares available for future grant and eliminate fungible share counting provisions with respect to new awards. Compensation |
Board | For | FOR 10 funds |
Split 2 FOR, 1 AGAINST |
| ACCOR SA | May 27, 2026 | Approve Compensation of Sébastien Bazin, Chairman and CEO Say-on-Pay |
Board | For | FOR 31 funds |
Split 1 FOR, 2 AGAINST |
| ACCOR SA | May 27, 2026 | Approve Remuneration Policy of Chairman and CEO Say-on-Pay |
Board | For | FOR 33 funds |
Split 1 FOR, 5 AGAINST |
| ACCOR SA | May 27, 2026 | Reelect Bruno Pavlovsky as Director Director Elections |
Board | For | FOR 16 funds |
Split 5 FOR, 1 AGAINST |
| ACCURAY INCORPORATED | November 13, 2025 | To conduct an advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 17 funds |
Split 1 FOR, 1 ABSTAIN |
| ACCURAY INCORPORATED | November 13, 2025 | To elect three Class I directors named in the accompanying proxy statement to serve until our 2028 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified. Anne B. Le Grand Director Elections |
Board | For | FOR 12 funds |
Split 1 FOR, 1 ABSTAIN |
| ACCURAY INCORPORATED | November 13, 2025 | To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2026. Audit-related |
Board | For | FOR 12 funds |
Split 1 FOR, 1 ABSTAIN |
| ACERINOX SA | May 5, 2026 | ADVISORY VOTE ON REMUNERATION REPORT Say-on-Pay |
Board | For | Split 14 FOR, 4 AGAINST |
AGAINST 1 fund |
| ACI WORLDWIDE, INC. | June 2, 2026 | To elect the nine directors named in the accompanying proxy statement to our Board of Directors to hold office until the 2027 Annual Meeting of Stockholders; Adalio T. Sanchez Director Elections |
Board | For | FOR 26 funds |
Split 4 FOR, 3 ABSTAIN |
| ACI WORLDWIDE, INC. | June 2, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026; Audit-related |
Board | For | FOR 26 funds |
Split 4 FOR, 3 ABSTAIN |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. Say-on-Pay |
Board | For | FOR 13 funds |
Split 2 AGAINST, 2 ABSTAIN |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Aclaris Therapeutics, Inc. for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 2 FOR, 2 ABSTAIN |
| ACM RESEARCH, INC. | June 10, 2026 | Ratification of appointment of Ernst & Young Hua Ming LLP as independent auditor for year 2026. Audit-related |
Board | For | FOR 20 funds |
Split 3 FOR, 1 ABSTAIN |
Page 1 of 66 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.